David Taras

David Taras

Auto-generated profile, based on publicly available information

David Taras

Lohmann Animal Health GmbH, Heinz-Lohmann-Straße 4, D-27472 Cuxhaven, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Obesity
Verified
Journal Article
Closed access
PDF file
Andreas SchwiertzAndreas Schwiertz
Andreas Schwiertz
DTDavid Taras
David Taras
KSKlaus Schäfer
Klaus Schäfer
SBSilvia Beijer
Silvia Beijer
NBNicolaas A. Bos
Nicolaas A. Bos
PHPhilip D. Hardt
Philip D. Hardt

1 May 2005 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
LSL. Scharek
L. Scharek
JGJ. Guth
J. Guth
KRK. Reiter
K. Reiter
KWK.D. Weyrauch
K.D. Weyrauch
DTD. Taras
D. Taras
KTK. Tedin
K. Tedin

1 March 2006 in Journal of Animal Science
Verified
Journal Article
Closed access
PDF file
DTD. Taras
D. Taras
WVW. Vahjen
W. Vahjen
MMM. Macha
M. Macha
OSO. Simon
O. Simon
As part of an interdisciplinary research project, the performance response of sows and their litters to the probiotic strain Enterococcus faecium NCIMB 10415, as well as some health characteristics of the piglets, were studied. Gestating sows (n = 26) were randomly allotted into 2 groups. The probiotic was administered by dietary supplementation to 1 group of sows and their respective litters (probiotic group), whereas the second group (control group) received no probiotic supplementation. The duration of the treatment was nearly 17 wk for sows (d 90 ante partum until d 28 postpartum) and 6 wk for piglets (d 15 to 56). Body weight and feed consumption were recorded weekly. The frequency of 4 toxin and 5 adhesion genes of putative pathogenic Escherichia coli was monitored weekly (d 7 to 35) by multiplex PCR assays, and fecal consistency of weaned piglets was studied daily. Probiotic treatment of lactating sows led to an overall pre-weaning mortality of 16.2% compared with 22.3% in the control group (P = 0.44). Animal losses during the first 3 d of the suckling period were decreased in the probiotic group (P = 0.09). For piglets (n = 153), which were weaned at 28 d, there were no overall treatment differences in BW gain, feed intake, or feed efficiency. Probiotic supplementation, however, led to nearly a 40% reduction (P = 0.012). The actual percentage of piglets with postweaning diarrhea in the probiotic group was 21% compared with 38% in the control group (P = 0.05). The study on virulence factors of dominant fecal E. coli isolates revealed a high diversity with varying frequency and distribution of each single pathogenicity gene. The 440 isolates carried 29 different pathogenicity gene combinations as well as each of the 9 pathogenicity genes alone. Altogether, isolates with more than 2 pathogenicity genes were quite rare (≤ 10%), and up until d 28 isolates without any pathogenicity gene occurred most frequently. Depending on the time of sampling, one-third or more of all isolates contained est2 or est1b as single gene or in combination with other pathogenicity genes.

1 March 2002 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Closed access
DTDavid Taras
David Taras
RSRainer Simmering
Rainer Simmering
MCMatthew D Collins
Matthew D Collins
PLPaul A Lawson
Paul A Lawson
MBMichael Blaut
Michael Blaut
Two strains of a gram-positively staining, obligately anaerobic, non-spore-forming, rod-shaped bacterium, designated strains 111-13A and 111-35T, were isolated from human faeces. Analysis of the 16S rRNA gene sequences indicated that these strains were members of the Clostridium coccoides rRNA group of organisms. The nearest relatives of the unknown bacterium were Eubacterium formicigenerans (having a sequence similarity of 94%) and an uncultured bacterium (similarity > 99%). Characterization studies indicated that the unidentified faecal bacterium was biochemically distinct from Eubacterium formicigenerans, members of the Clostridium coccoides group and all other described Eubacterium species. On the basis of the data from these studies, it is proposed that the hitherto unknown rod-shaped bacterium be designated a species of a novel genus, namely Dorea longicatena gen. nov., sp. nov., and that Eubacterium formicigenerans be transferred to this genus as Dorea formicigenerans gen. nov., comb. nov.

1 January 2006 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
AGA. Gostner
A. Gostner
MBM. Blaut
M. Blaut
VSV. Schäffer
V. Schäffer
GKG. Kozianowski
G. Kozianowski
STS. Theis
S. Theis
WSW. Scheppach
W. Scheppach
Due to its low digestibility in the small intestine, a major fraction of the polyol isomalt reaches the colon. However, little is known about effects on the intestinal microflora. During two 4-week periods in a double-blind, placebo-controlled, cross-over design, nineteen healthy volunteers consumed a controlled basal diet enriched with either 30g isomalt or 30g sucrose daily. Stools were collected at the end of each test phase and various microbiological and luminal markers were analysed. Fermentation characteristics of isomalt were also investigatedin vitro. Microbiological analyses of faecal samples indicated a shift of the gut flora towards an increase of bifidobacteria following consumption of the isomalt diet compared with the sucrose diet (P<0·05). During the isomalt phase, the activity of bacterial β-glucosidase decreased (P<0·05) whereas β-glucuronidase, sulfatase, nitroreductase and urease remained unchanged. Faecal polyamines were not different between test periods with the exception of cadaverine, which showed a trend towards a lower concentration following isomalt (P=0·055). Faecal SCFA, lactate, bile acids, neutral sterols, N, NH3, phenol andp-cresol were not affected by isomalt consumption.In vitro, isomalt was metabolized in several bifidobacteria strains and yielded high butyrate concentrations. Isomalt, which is used widely as a low-glycaemic and low-energy sweetener, has to be considered a prebiotic carbohydrate that might contribute to a healthy luminal environment of the colonic mucosa.

1 May 2009 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
ISIstván Szabó
István Szabó
LWLothar H. Wieler
Lothar H. Wieler
KTKarsten Tedin
Karsten Tedin
LSLydia Scharek-Tedin
Lydia Scharek-Tedin
DTDavid Taras
David Taras
KNKarsten Nöckler
Karsten Nöckler
The beneficial effects of probioticEnterococcusspp. in different hosts, such as mice and humans, have previously been reported in several studies. However, studies of large domestic animals, as well as challenge studies with pathogenic microorganisms, are very rare. Here, we investigated the influence of oral treatment of pigs with the probiotic bacteriumEnterococcus faeciumNCIMB 10415 onSalmonella entericaserovar Typhimurium DT104 infections in weaning piglets. Clinical symptoms, fecal excretion, the organ distribution ofSalmonella, and the humoral immune response (immunoglobulin G [IgG], IgM, and IgA levels) in serum were examined. A pool of 89 piglets was randomly divided into probiotic and control groups. The probiotic group received a feed supplement containingE. faeciumstarting on day 14 postpartum prior to challenge withSalmonellaserovar Typhimurium DT104 at 28 days postpartum. After challenge withSalmonellaserovar Typhimurium DT104, piglets in both groups showed no severe clinical signs of salmonellosis. However, fecal excretion and colonization ofSalmonellain organs were significantly greater in piglets fedE. faecium. Likewise, the humoral immune response againstSalmonella(serum IgM and IgA levels) was significantly greater in the probiotic group animals than in control animals. The results of this study suggest thatE. faeciumNCIMB 10415 treatment enhanced the course of infection in weaning piglets challenged withSalmonellaserovar Typhimurium DT104. However, the probiotic treatment also appeared to result in greater production of specific antibodies againstSalmonellaserovar Typhimurium DT104.